Grant: Idea to Innovation
Ryerson University
$125,000.00
Development of an accoustic and photoacoustic flow cytometer
FY 2014-15
Summary
The main objective of this study is to develop an automated cell analyzer that counts, sizes, and determines the morphology and internal structure of cells using sound waves. In this device, a laser and an ultrasound transducer are integrated into a microfluidic flow system where cells are streamed through the target area one by one. Each cell is irradiated by an ultrasound wave (which is reflected from the cell) and a laser pulse (which produces a photoacoustic wave from the cell). Each cell type has a unique acoustic signature, from which the size, morphology, and internal structure can be determined. These parameters can be extracted using signal processing methods, and then used to identify each cell type. High-frequency sound waves have distinct advantages over other methods used in particle analyzers as they are highly sensitive to the morphology and internal structure of cells, providing increased sensitivity and specificity for the identification of each cell type in a sample. Applications pursued using this technology include examination of blood samples for the identification of blood pathologies, and the detection of circulating tumor cells. Identification of circulating tumor cells in the blood can be used as an early warning system for cancer progression prior to the patient showing symptoms, ultimately improving patient treatment, and lowering mortality rates and healthcare costs.
Program
Idea to Innovation
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
470611-2014
Name nom
Kolios, Michael
Department département
Physics
Organization id
43
Institution établissement
Ryerson University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
125000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
3114
Research subject group en
Physics
Research subject group fr
Physique
Research subject en
Biological and Medical Physics
Research subject fr
Physique biologique et médicale
Partie
1
Nb partie
1
Application title
Development of an accoustic and photoacoustic flow cytometer
Keyword
NSERC
Application summary
The main objective of this study is to develop an automated cell analyzer that counts, sizes, and determines the morphology and internal structure of cells using sound waves. In this device, a laser and an ultrasound transducer are integrated into a microfluidic flow system where cells are streamed through the target area one by one. Each cell is irradiated by an ultrasound wave (which is reflected from the cell) and a laser pulse (which produces a photoacoustic wave from the cell). Each cell type has a unique acoustic signature, from which the size, morphology, and internal structure can be determined. These parameters can be extracted using signal processing methods, and then used to identify each cell type. High-frequency sound waves have distinct advantages over other methods used in particle analyzers as they are highly sensitive to the morphology and internal structure of cells, providing increased sensitivity and specificity for the identification of each cell type in a sample. Applications pursued using this technology include examination of blood samples for the identification of blood pathologies, and the detection of circulating tumor cells. Identification of circulating tumor cells in the blood can be used as an early warning system for cancer progression prior to the patient showing symptoms, ultimately improving patient treatment, and lowering mortality rates and healthcare costs.